Cargando…
Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma
Background: Active vitreous seeds in eyes with retinoblastoma (Rb) adversely affects the treatment outcome. This study aimed to investigate the safety and efficacy of intravitreal melphalan chemotherapy (IViC) as a treatment for recurrent and refractory vitreous seeds in patients with Rb. Methods: W...
Autores principales: | Yousef, Yacoub A., Al Jboor, Mays, Mohammad, Mona, Mehyar, Mustafa, Toro, Mario D., Nazzal, Rashed, Alzureikat, Qusai H., Rejdak, Magdalena, Elfalah, Mutasem, Sultan, Iyad, Rejdak, Robert, Al-Hussaini, Maysa, Al-Nawaiseh, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311556/ https://www.ncbi.nlm.nih.gov/pubmed/34322023 http://dx.doi.org/10.3389/fphar.2021.696787 |
Ejemplares similares
-
Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma
por: Yousef, Yacoub A., et al.
Publicado: (2020) -
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma
por: Amin, Saima, et al.
Publicado: (2021) -
A Proposal for Future Modifications on Clinical TNM Staging System of Retinoblastoma Based on the American Joint Committee on Cancer Staging Manual, 7(th) and 8(th) Editions
por: Yousef, Yacoub A., et al.
Publicado: (2022) -
Intravitreal melphalan for persistent retinoblastoma vitreous seeds
por: Redondo-Villanueva, Marie Jeazelle H., et al.
Publicado: (2022) -
Resistant retinoblastoma in a 23-year-old patient
por: Yousef, Yacoub A., et al.
Publicado: (2014)